Q Codes
- Bart Rogacewicz
Q0035 | Cardiokymography |
Q0081 | Infusion therapy, using other than chemotherapeutic drugs, per visit |
Q0083 | Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit |
Q0084 | Chemotherapy administration by infusion technique only, per visit |
Q0085 | Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit |
Q0090 | Levonorgestrel-releasing intrauterine contraceptive system, (skyla), 13.5 mg |
Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
Q0092 | Set-up portable x-ray equipment |
Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens |
Q0112 | All potassium hydroxide (koh) preparations |
Q0113 | Pinworm examinations |
Q0114 | Fern test |
Q0115 | Post-coital direct, qualitative examinations of vaginal or cervical mucous |
Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
Q0139 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) |
Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram |
Q0161 | Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
Q0164 | Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0165 | Prochlorperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0166 | Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
Q0167 | Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0168 | Dronabinol, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0169 | Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0170 | Promethazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0171 | Chlorpromazine hydrochloride, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0172 | Chlorpromazine hydrochloride, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0173 | Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0174 | Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0175 | Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0176 | Perphenazine, 8mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0178 | Hydroxyzine pamoate, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0180 | Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
Q0181 | Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
Q0478 | Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type |
Q0479 | Power module for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0480 | Driver for use with pneumatic ventricular assist device, replacement only |
Q0481 | Microprocessor control unit for use with electric ventricular assist device, replacement only |
Q0482 | Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only |
Q0483 | Monitor/display module for use with electric ventricular assist device, replacement only |
Q0484 | Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0485 | Monitor control cable for use with electric ventricular assist device, replacement only |
Q0486 | Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only |
Q0487 | Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only |
Q0488 | Power pack base for use with electric ventricular assist device, replacement only |
Q0489 | Power pack base for use with electric/pneumatic ventricular assist device, replacement only |
Q0490 | Emergency power source for use with electric ventricular assist device, replacement only |
Q0491 | Emergency power source for use with electric/pneumatic ventricular assist device, replacement only |
Q0492 | Emergency power supply cable for use with electric ventricular assist device, replacement only |
Q0493 | Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only |
Q0494 | Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0495 | Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0496 | Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0497 | Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0498 | Holster for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0499 | Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only |
Q0500 | Filters for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0501 | Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0502 | Mobility cart for pneumatic ventricular assist device, replacement only |
Q0503 | Battery for pneumatic ventricular assist device, replacement only, each |
Q0504 | Power adapter for pneumatic ventricular assist device, replacement only, vehicle type |
Q0505 | Miscellaneous supply or accessory for use with ventricular assist device |
Q0506 | Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only |
Q0507 | Miscellaneous supply or accessory for use with an external ventricular assist device |
Q0508 | Miscellaneous supply or accessory for use with an implanted ventricular assist device |
Q0509 | Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a |
Q0510 | Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant |
Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period |
Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period |
Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days |
Q0514 | Pharmacy dispensing fee for inhalation drug(s); per 90 days |
Q0515 | Injection, sermorelin acetate, 1 microgram |
Q1004 | New technology intraocular lens category 4 as defined in federal register notice |
Q1005 | New technology intraocular lens category 5 as defined in federal register notice |
Q2004 | Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml |
Q2009 | Injection, fosphenytoin, 50 mg phenytoin equivalent |
Q2017 | Injection, teniposide, 50 mg |
Q2026 | Injection, radiesse, 0.1 ml |
Q2027 | Injection, sculptra, 0.1 ml |
Q2028 | Injection, sculptra, 0.5 mg |
Q2033 | Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok) |
Q2034 | Influenza virus vaccine, split virus, for intramuscular use (agriflu) |
Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
Q2039 | Influenza virus vaccine, not otherwise specified |
Q2043 | Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion |
Q2049 | Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg |
Q2050 | Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg |
Q2051 | Injection, zoledronic acid, not otherwise specified, 1mg |
Q2052 | Services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration |
Q3001 | Radioelements for brachytherapy, any type, each |
Q3014 | Telehealth originating site facility fee |
Q3025 | Injection, interferon beta-1a, 11 mcg for intramuscular use |
Q3026 | Injection, interferon beta-1a, 11 mcg for subcutaneous use |
Q3027 | Injection, interferon beta-1a, 1 mcg for intramuscular use |
Q3028 | Injection, interferon beta-1a, 1 mcg for subcutaneous use |
Q3031 | Collagen skin test |
Q4001 | Casting supplies, body cast adult, with or without head, plaster |
Q4002 | Cast supplies, body cast adult, with or without head, fiberglass |
Q4003 | Cast supplies, shoulder cast, adult (11 years +), plaster |
Q4004 | Cast supplies, shoulder cast, adult (11 years +), fiberglass |
Q4005 | Cast supplies, long arm cast, adult (11 years +), plaster |
Q4006 | Cast supplies, long arm cast, adult (11 years +), fiberglass |
Q4007 | Cast supplies, long arm cast, pediatric (0-10 years), plaster |
Q4008 | Cast supplies, long arm cast, pediatric (0-10 years), fiberglass |
Q4009 | Cast supplies, short arm cast, adult (11 years +), plaster |
Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass |
Q4011 | Cast supplies, short arm cast, pediatric (0-10 years), plaster |
Q4012 | Cast supplies, short arm cast, pediatric (0-10 years), fiberglass |
Q4013 | Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster |
Q4014 | Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass |
Q4015 | Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster |
Q4016 | Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass |
Q4017 | Cast supplies, long arm splint, adult (11 years +), plaster |
Q4018 | Cast supplies, long arm splint, adult (11 years +), fiberglass |
Q4019 | Cast supplies, long arm splint, pediatric (0-10 years), plaster |
Q4020 | Cast supplies, long arm splint, pediatric (0-10 years), fiberglass |
Q4021 | Cast supplies, short arm splint, adult (11 years +), plaster |
Q4022 | Cast supplies, short arm splint, adult (11 years +), fiberglass |
Q4023 | Cast supplies, short arm splint, pediatric (0-10 years), plaster |
Q4024 | Cast supplies, short arm splint, pediatric (0-10 years), fiberglass |
Q4025 | Cast supplies, hip spica (one or both legs), adult (11 years +), plaster |
Q4026 | Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass |
Q4027 | Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster |
Q4028 | Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass |
Q4029 | Cast supplies, long leg cast, adult (11 years +), plaster |
Q4030 | Cast supplies, long leg cast, adult (11 years +), fiberglass |
Q4031 | Cast supplies, long leg cast, pediatric (0-10 years), plaster |
Q4032 | Cast supplies, long leg cast, pediatric (0-10 years), fiberglass |
Q4033 | Cast supplies, long leg cylinder cast, adult (11 years +), plaster |
Q4034 | Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass |
Q4035 | Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster |
Q4036 | Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass |
Q4037 | Cast supplies, short leg cast, adult (11 years +), plaster |
Q4038 | Cast supplies, short leg cast, adult (11 years +), fiberglass |
Q4039 | Cast supplies, short leg cast, pediatric (0-10 years), plaster |
Q4040 | Cast supplies, short leg cast, pediatric (0-10 years), fiberglass |
Q4041 | Cast supplies, long leg splint, adult (11 years +), plaster |
Q4042 | Cast supplies, long leg splint, adult (11 years +), fiberglass |
Q4043 | Cast supplies, long leg splint, pediatric (0-10 years), plaster |
Q4044 | Cast supplies, long leg splint, pediatric (0-10 years), fiberglass |
Q4045 | Cast supplies, short leg splint, adult (11 years +), plaster |
Q4046 | Cast supplies, short leg splint, adult (11 years +), fiberglass |
Q4047 | Cast supplies, short leg splint, pediatric (0-10 years), plaster |
Q4048 | Cast supplies, short leg splint, pediatric (0-10 years), fiberglass |
Q4049 | Finger splint, static |
Q4050 | Cast supplies, for unlisted types and materials of casts |
Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
Q4074 | Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms |
Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) |
Q4082 | Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap) |
Q4100 | Skin substitute, not otherwise specified |
Q4101 | Apligraf, per square centimeter |
Q4102 | Oasis wound matrix, per square centimeter |
Q4103 | Oasis burn matrix, per square centimeter |
Q4104 | Integra bilayer matrix wound dressing (bmwd), per square centimeter |
Q4105 | Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter |
Q4106 | Dermagraft, per square centimeter |
Q4107 | Graftjacket, per square centimeter |
Q4108 | Integra matrix, per square centimeter |
Q4110 | Primatrix, per square centimeter |
Q4111 | Gammagraft, per square centimeter |
Q4112 | Cymetra, injectable, 1 cc |
Q4113 | Graftjacket xpress, injectable, 1 cc |
Q4114 | Integra flowable wound matrix, injectable, 1 cc |
Q4115 | Alloskin, per square centimeter |
Q4116 | Alloderm, per square centimeter |
Q4117 | Hyalomatrix, per square centimeter |
Q4118 | Matristem micromatrix, 1 mg |
Q4119 | Matristem wound matrix, per square centimeter |
Q4120 | Matristem burn matrix, per square centimeter |
Q4121 | Theraskin, per square centimeter |
Q4122 | Dermacell, per square centimeter |
Q4123 | Alloskin rt, per square centimeter |
Q4124 | Oasis ultra tri-layer wound matrix, per square centimeter |
Q4125 | Arthroflex, per square centimeter |
Q4126 | Memoderm, dermaspan, tranzgraft or integuply, per square centimeter |
Q4127 | Talymed, per square centimeter |
Q4128 | Flex hd, allopatch hd, or matrix hd, per square centimeter |
Q4129 | Unite biomatrix, per square centimeter |
Q4130 | Strattice tm, per square centimeter |
Q4131 | Epifix or epicord, per square centimeter |
Q4132 | Grafix core, per square centimeter |
Q4133 | Grafix prime, per square centimeter |
Q4134 | Hmatrix, per square centimeter |
Q4135 | Mediskin, per square centimeter |
Q4136 | Ez-derm, per square centimeter |
Q4137 | Amnioexcel or biodexcel, per square centimeter |
Q4138 | Biodfence dryflex, per square centimeter |
Q4139 | Amniomatrix or biodmatrix, injectable, 1 cc |
Q4140 | Biodfence, per square centimeter |
Q4141 | Alloskin ac, per square centimeter |
Q4142 | Xcm biologic tissue matrix, per square centimeter |
Q4143 | Repriza, per square centimeter |
Q4145 | Epifix, injectable, 1 mg |
Q4146 | Tensix, per square centimeter |
Q4147 | Architect, architect px, or architect fx, extracellular matrix, per square centimeter |
Q4148 | Neox 1k, per square centimeter |
Q4149 | Excellagen, 0.1 cc |
Q4150 | Allowrap ds or dry, per square centimeter |
Q4151 | Amnioband or guardian, per square centimeter |
Q4152 | Dermapure, per square centimeter |
Q4153 | Dermavest and plurivest, per square centimeter |
Q4154 | Biovance, per square centimeter |
Q4155 | Neoxflo or clarixflo, 1 mg |
Q4156 | Neox 100, per square centimeter |
Q4157 | Revitalon, per square centimeter |
Q4158 | Marigen, per square centimeter |
Q4159 | Affinity, per square centimeter |
Q4160 | Nushield, per square centimeter |
Q4161 | Bio-connekt wound matrix, per square centimeter |
Q4162 | Amniopro flow, bioskin flow, biorenew flow, woundex flow, amniogen-a, amniogen-c, 0.5 cc |
Q4163 | Amniopro, bioskin, biorenew, woundex, amniogen-45, amniogen-200, per square centimeter |
Q4164 | Helicoll, per square centimeter |
Q4165 | Keramatrix, per square centimeter |
Q4166 | Cytal, per square centimeter |
Q4167 | Truskin, per square centimeter |
Q4168 | Amnioband, 1 mg |
Q4169 | Artacent wound, per square centimeter |
Q4170 | Cygnus, per square centimeter |
Q4171 | Interfyl, 1 mg |
Q4172 | Puraply or puraply am, per square centimeter |
Q4173 | Palingen or palingen xplus, per square centimeter |
Q4174 | Palingen or promatrx, 0.36 mg per 0.25 cc |
Q4175 | Miroderm, per square centimeter |
Q5001 | Hospice or home health care provided in patient's home/residence |
Q5002 | Hospice or home health care provided in assisted living facility |
Q5003 | Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf) |
Q5004 | Hospice care provided in skilled nursing facility (snf) |
Q5005 | Hospice care provided in inpatient hospital |
Q5006 | Hospice care provided in inpatient hospice facility |
Q5007 | Hospice care provided in long term care facility |
Q5008 | Hospice care provided in inpatient psychiatric facility |
Q5009 | Hospice or home health care provided in place not otherwise specified (nos) |
Q5010 | Hospice home care provided in a hospice facility |
Q5101 | Injection, filgrastim (g-csf), biosimilar, 1 microgram |
Q5102 | Injection, infliximab, biosimilar, 10 mg |
Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml |
Q9951 | Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
Q9953 | Injection, iron-based magnetic resonance contrast agent, per ml |
Q9954 | Oral magnetic resonance contrast agent, per 100 ml |
Q9955 | Injection, perflexane lipid microspheres, per ml |
Q9956 | Injection, octafluoropropane microspheres, per ml |
Q9957 | Injection, perflutren lipid microspheres, per ml |
Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
Q9959 | High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml |
Q9960 | High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
Q9961 | High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml |
Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
Q9964 | High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml |
Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
Q9968 | Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
Q9970 | Injection, ferric carboxymaltose, 1mg |
Q9972 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
Q9973 | Injection, epoetin beta, 1 microgram, (non-esrd use) |
Q9974 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
Q9975 | Injection, factor viii fc fusion protein (recombinant), per iu |
Q9976 | Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron |
Q9977 | Compounded drug, not otherwise classified |
Q9978 | Netupitant 300 mg and palonosetron 0.5 mg |
Q9979 | Injection, alemtuzumab, 1 mg |
Q9980 | Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg |
Q9981 | Rolapitant, oral, 1 mg |
Q9982 | Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries |
Q9983 | Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries |